Detailed comparison on parameters like NAV | Returns | Risk | Rating | Analysis
Risk  | Very High  | Very High  | 
Rating  | 1.0  | 5.0  | 
Min SIP Amount  | ₹500  | ₹100  | 
Expense Ratio  | 1.05  | 1.36  | 
NAV  | ₹14.09  | ₹200.79  | 
Fund Started  | 28 Mar 2022  | 07 May 2007  | 
Fund Size  | ₹255.55 Cr  | ₹84854.73 Cr  | 
Exit Load  | -  | Exit load of 1% if redeemed within 1 year.  | 
Risk
Rating
Min SIP Amount
Expense Ratio
NAV
Fund Started
Fund Size
Exit Load
1 Year  | -1.70%  | 7.61%  | 
3 Year  | 13.77%  | 25.90%  | 
5 Year  | -  | 29.74%  | 
1 Year
3 Year
5 Year
Equity  | 99.91%  | 93.60%  | 
Cash  | 0.09%  | 6.40%  | 
Equity
Cash
Top 10 Holdings  | 
  | 
  | 
Top 10 Holdings
Name  | Assets  | 
|---|---|
Colgate-Palmolive (India) Ltd.  | 4.68%  | 
HDFC Asset Management Company Ltd.  | 3.83%  | 
Cummins India Ltd.  | 3.41%  | 
Dixon Technologies (India) Ltd.  | 3.37%  | 
Marico Ltd.  | 3.24%  | 
Polycab India Ltd.  | 2.81%  | 
Hindustan Zinc Ltd.  | 2.81%  | 
Coforge Ltd.  | 2.72%  | 
Persistent Systems Ltd.  | 2.66%  | 
Page Industries Ltd.  | 2.57%  | 
Name  | Assets  | 
|---|---|
Max Financial Services Ltd.  | 4.76%  | 
Balkrishna Industries Ltd.  | 3.54%  | 
Indian Bank  | 3.26%  | 
Fortis Healthcare Ltd.  | 3.18%  | 
AU Small Finance Bank Ltd.  | 3.16%  | 
Coforge Ltd.  | 2.93%  | 
The Federal Bank Ltd.  | 2.91%  | 
Hindustan Petroleum Corporation Ltd.  | 2.90%  | 
Glenmark Pharmaceuticals Ltd.  | 2.87%  | 
Ipca Laboratories Ltd.  | 2.80%  | 
Name  | Sharwan Kumar Goyal  | Chirag Setalvad  | 
Start Date  | 28 Jan 2025  | 28 Jun 2014  | 
Name
Start Date
Description  | The scheme seeks to provide returns that, before expenses, closely correspond to the total returns of the securities as represented by the underlying index, subject to tracking error.  | The scheme seeks to provide long-term capital appreciation/income by investing predominantly in Mid-Cap companies.  | 
Launch Date  | 28 Mar 2022  | 07 May 2007  | 
Description
Launch Date